18-Jul-2023 | R | 1:16 Rights Issues of Equity Shares
Trading Members of the Exchange are hereby informed that BROOKS LABORATORIES LIMITED has fixed Record Date for the purpose of Rights Issue of Equity Shares of the Company. The transactions in the Equity Shares of the Company should be done on Ex-Rights Basis with effect from the under mentioned date :-
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
BROOKS LABORATORIES LIMITED
(533543)
RECORD DATE
28/07/2023
PURPOSE
Issue of 1 (One) Equity Share of Rs.10/- each for cash at a Premium of Rs. 65/- per Share on Rights Basis for every 16 (Sixteen) Equity Shares held.*
Ex-Right basis from Date & Sett. No.
28/07/2023 DR-581/2023-2024
*As per Terms of Payment : Issue Price of Rs.75/- - Full amount to be paid on the day of Application
Trading Members of the Exchange are requested to take note of it.
(As Per BSE Notice Dated on 25.07.2023) | 28-Jul-2023 | 1:16 |
31-Jan-2020 | R | 9:20 Rights Issue of Equity Shares
Trading Members of the Exchange are hereby informed that, Brooks Laboratories Limited has fixed the Record date for the purpose of Rights Issue of Equity Shares. The transactions in the equity shares of the Company should be done on ex-rights basis with effect from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Brooks Laboratories Limited
(533543)
RECORD DATE
12.02.2020
PURPOSE
Issue of 9 (Nine) equity shares of Rs. 20/- each on rights basis for cash at premium of Rs.10/- per share for every 20 (Twenty) equity shares held.
Ex-Right basis from Date & Sett. No.
11/02/2020 DR-216/2019-2020
Trading Members of the Exchange are requested to take note of it.
(As Per BSE Notice Dated on 03.02.2020) | 12-Feb-2020 | 9:20 |
24-Jan-2024 | BC | BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve the unaudited standalone and consolida | 31-Jan-2024 | |
16-Jan-2024 | BC | BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 inter alia to consider and approve fund raising through Rights issue.
| 24-Jan-2024 | |
31-Oct-2023 | BC | BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve the unaudited standalone and consolida | 09-Nov-2023 | |
30-Aug-2023 | BC | Reg. 34 (1) Annual Report.
Newspaper advertisement for conducting 21st AGM
Notice of 21st AGM
(As Per BSE Announcement Dated on 01/09/2023)
Proceedings and Outcome of 21st AGM held on 21s | 21-Sep-2023 | |
30-Aug-2023 | BC | Reg. 34 (1) Annual Report.
| 15-Sep-2023 | |
No Dividends has been declared by BROOKSLABORATORIES
No Bonus has been declared by BROOKSLABORATORIES
No Split has been declared by BROOKSLABORATORIES
RightsRecord Date01 Jan'1900
Ex-Rights Date01 Jan'1900
Premium(Rs.)65
Ratio1:16
Record Date01 Jan'1900
Ex-Rights Date01 Jan'1900
Premium(Rs.)10
Ratio9:20
Book Closure
31-Jan-2024 | - | BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve the unaudited standalone and consolida |
24-Jan-2024 | - | BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 inter alia to consider and approve fund raising through Rights issue.
|
09-Nov-2023 | - | BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve the unaudited standalone and consolida |
21-Sep-2023 | - | Reg. 34 (1) Annual Report.
Newspaper advertisement for conducting 21st AGM
Notice of 21st AGM
(As Per BSE Announcement Dated on 01/09/2023)
Proceedings and Outcome of 21st AGM held on 21s |
15-Sep-2023 | 01 Jan'1900 | Reg. 34 (1) Annual Report.
|